Clinical CareFor People With Sickle Cell Disease, ERs Can Mean Life-Threatening Waits
A crisis can quickly escalate into life-threatening complications such as strokes, seizures, and sepsis.
TechnologyDEA Extending Telemedicine Prescription Waiver Through 2024
The agency is once again extending a pandemic-era waiver enabling providers to prescribe controlled substances via telemedicine without first needing...
TechnologyMulti-State Pilot to Test the Value of RPM for Methadone Treatment
The University of Washington School of Medicine and Scene Health are continuing a federally funded project that uses video-based remote...
TechnologyDEA Schedules Listening Sessions to Discuss Telemedicine Prescriptions
The agency will meet in September with interested parties to discuss a long-debated proposed registration for providers wishing to prescribe...
MarketingDoctors Sound Alarm About Child Nicotine Poisoning as Vapes Flood the U.S. Market
Cases of vaping-related nicotine exposure reported to poison centers hit an all-time high in 2022.
TelehealthRemote Testing Proves Effective for Opioid Screening
More than 83% of patients in the study completed multiple remote urine screenings within the first 30 days of entering...
InnovationIs Digital Health Meeting Its Goals in Substance Abuse Treatment?
A new study finds that a third of providers surveyed are using digital health to treat OUD and substance abuse,...
TelehealthThe DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In.
Controlled medications include many stimulants, sedatives, opioid painkillers, and anabolic steroids.
Clinical CareClinicians Missing Opportunity to Medicate Patients for Alcohol Use Disorder
A new study has found that very few patients hospitalized with alcohol use disorder are prescribed appropriate medications such as...
Clinical CareAMA Adopts More Than Dozen New Policies
The American Medical Association has created or strengthen policies to promote public health and advocate for new laws and regulations.
PharmaIndivior, 42 AGs Reach $102M Suboxone Antitrust Settlement
The AGs had claimed that Invidior used 'product hopping' to block competition from generics for its opioid treatment drug.
InnovationFederally-Funded Study to Test Value of Overdose Prevention Centers
NYU Langone Health and the Brown University School of Public Health will conduct a five-year study on the effectiveness of...